340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Specialty Drug Hyperinflation Threatens Drug Access


 

Print Article

The price of specialty drugs is far outstripping inflation, according to a new white paper from the Campaign for Sustainable Rx Pricing.

Between 2012 and 2013, specialty drugs for inflammatory conditions rose 15 percent; for multiple sclerosis 14.7 percent and for cancer 13.6 percent, according to the report. Meanwhile, consumer prices rose just 1.5 percent.

“Large, compounded price increases in already expensive specialty products yield cost increases that greatly exceed those of any other prescription drug product on the market,”  the report says. “This creates a situation in which products that were priced virtually out-of-reach at the time of their launch become increasingly inaccessible and unaffordable over time due to inflation.”

The report warns that patients with chronic conditions like HIV/AIDS, cancer and multiple sclerosis are particularly at risk because they must take their medicines on a long-term basis.

The takeaway? “The status quo is unsustainable – our health care system cannot afford the unrelenting specialty drug price increases and devastating cost burden.”

The 340B program was born in 1992 as the result of sky-high drug prices. Safety-net hospitals treat a disproportionate share of patients with complex, chronic conditions. As specialty medicines continue to bust the bank, the program is more important than ever in helping hospitals provide affordable meds to this particularly vulnerable population.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS 340B Employed

  • Specialty Pharmacy Manager needed in Southwestern Missouri Health System JOB-3068922 | CompHealth July 10, 2025
  • Coordinator Pharmacy 340B Program - Longview Pharmacy - Full Time | CHRISTUS Health July 10, 2025
  • Pharmacist - 340B Coordinator - Hybrid | Cedars Sinai July 10, 2025
  • Compliance Analyst, 340B Program ( On-Site ) | WMCHealth July 10, 2025
  • Pharmacy Business Manager | Nemours July 10, 2025

Copyright © 2025 · 340B Health